Enhancement of cisplatin cytotoxicity in combination with herniarin in vitro

References

• Ahmad A, Misra LN. (1997). Isolation of herniarin and other constituents from Matricaria chamomilla flowers. Int J Pharm 35:121–125
   Google Scholar
• Askari M, Sahebkar A, Iranshahi M. (2009). Synthesis and purification of 7-prenyloxycoumarins and herniarin as bioactive natural coumarins. IJBMS 12:63–69
   Google Scholar
• Behnam Rassouli F, Matin MM, Iranshahi M, et al. (2009). Mogoltacin enhances vincristine cytotoxicity in human transitional cell carcinoma (TCC) cell line. Phytomedicine 16:181–187
   PubMed Web of Science ®Google Scholar
• Brown SA. (1963). Biosynthesis of the coumarins IV. The formation of coumarin and herniarin in Lavander. Phytochemistry 2:137–144
   Web of Science ®Google Scholar
• Budzisz E, Brzezinska E, Krajewska U, Rozalski M. (2003). Cytotoxic effects, alkylating properties and molecular modelling of coumarin derivatives and their phosphonic analogues. Eur J Med Chem 38:597–603
   PubMed Web of Science ®Google Scholar
• Cepeda V, Fuertes MA, Castilla J, et al. (2007). Biochemical mechanisms of cisplatin cytotoxicity. Anticancer Agents Med Chem 7:3–18
   PubMed Web of Science ®Google Scholar
• Chu CY, Tsai YY, Wang CJ, et al. (2001). Induction of apoptosis by esculetin in human leukemia cells. Eur J Pharmacol 416:25–32
   PubMed Web of Science ®Google Scholar
• Cooke D, O’Kennedy R. (1999). Comparison of the tetrazolium salt assay for succinate dehydrogenase with the cytosensor microphysiometer in the assessment of compound toxicities. Anal Biochem 274:188–194
   PubMed Web of Science ®Google Scholar
• Egan D, James P, Cooke D, O’Kennedy R. (1997). Studies on the cytostatic and cytotoxic effects and mode of action of 8-nitro-7-hydroxycoumarin. Cancer Lett 118:201–211
   PubMed Web of Science ®Google Scholar
• Feuer G. (1974). The metabolism and biological actions of coumarins. Prog Med Chem 10:85–158
   PubMedGoogle Scholar
• Finn G, Creaven B, Egan D. (2003). Modulation of mitogen-activated protein kinases by 6-nitro-7-hydroxycoumarin mediates apoptosis in renal carcinoma cells. Eur J Pharmacol 481:159–167
   PubMed Web of Science ®Google Scholar
• Finn GJ, Creaven B, Egan DA. (2001). Study of the in vitro cytotoxic potential of natural and synthetic coumarin derivatives using human normal and neoplastic skin cell lines. Melanoma Res 11:461–467
   PubMed Web of Science ®Google Scholar
• Fresco P, Borges F, Diniz C, Marques MP. (2006). New insights on the anticancer properties of dietary polyphenols. Med Res Rev 26:747–766
   PubMed Web of Science ®Google Scholar
• Jiménez-Orozco FA, López-González JS, Nieto-Rodriguez A, et al. (2001). Decrease of cyclin D1 in the human lung adenocarcinoma cell line A-427 by 7-hydroxycoumarin. Lung Cancer 34:185–194
   PubMed Web of Science ®Google Scholar
• Kawase M, Sakagami H, Hashimoto K, et al. (2003). Structure-cytotoxic activity relationships of simple hydroxylated coumarins. Anticancer Res 23:3243–3246
   PubMed Web of Science ®Google Scholar
• Kerr JF, Winterford CM, Harmon BV. (1994). Apoptosis. Its significance in cancer and cancer therapy. Cancer 73:2013–2026
   PubMed Web of Science ®Google Scholar
• Kerr JF, Wyllie AH, Currie AR. (1972). Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26:239–257
   PubMed Web of Science ®Google Scholar
• Kostova I. (2005). Synthetic and natural coumarins as cytotoxic agents. Curr Med Chem Anticancer Agents 5:29–46
   PubMed Web of Science ®Google Scholar
• Kundra V, Silverman PM. (2003). Imaging in the diagnosis, staging, and follow-up of cancer of the urinary bladder. AJR Am J Roentgenol 180:1045–1054
   PubMed Web of Science ®Google Scholar
• Lacy A, O’Kennedy R. (2004). Studies on coumarins and coumarin-related compounds to determine their therapeutic role in the treatment of cancer. Curr Pharm Des 10:3797–3811
   PubMed Web of Science ®Google Scholar
• Leist M, Jaattela M. (2001). Four deaths and a funeral: from caspases to alternative mechanisms. Nat Rev Mol Cell Biol 2:589–598
   PubMed Web of Science ®Google Scholar
• Lopez-Gonzalez JS, Prado-Garcia H, Aguilar-Cazares D, et al. (2004). Apoptosis and cell cycle disturbances induced by coumarin and 7-hydroxycoumarin on human lung carcinoma cell lines. Lung Cancer 43:275–283
   PubMed Web of Science ®Google Scholar
• Lorusso V, Silvestris N. (2005). Systemic chemotherapy for patients with advanced and metastatic bladder cancer: current status and future directions. Ann Oncol 16:iv85–89
   PubMedGoogle Scholar
• Ma CM, Winsor L, Daneshtalab M. (2007). Quantification of spiroether isomers and herniarin of different parts of Matricaria matricarioides and flowers of Chamaemelum nobile. Phytochem Anal 18:42–49
   PubMed Web of Science ®Google Scholar
• Mahmoud NN, Carothers AM, Grunberger D, et al. (2000). Plant phenolics decrease intestinal tumors in an animal model of familial adenomatous polyposis. Carcinogenesis 21:921–927
   PubMed Web of Science ®Google Scholar
• Marshall ME, Butler K, Fried A. (1991). Phase I evaluation of coumarin (1,2-benzopyrone) and cimetidine in patients with advanced malignancies. Mol Biother 3:170–178
   PubMedGoogle Scholar
• Marshall ME, Kervin K, Benefield C, et al. (1994). Growth-inhibitory effects of coumarin (1,2-benzopyrone) and 7-hydroxycoumarin on human malignant cell lines in vitro. J Cancer Res Clin Oncol 120:S3–10
   PubMed Web of Science ®Google Scholar
• Maucher A, Von Angerer E. (1994). Antitumor activity of coumarin and 7-hydroxycoumarin against 7,12-dimethylbenz[a]anthracene-induced rat mammary carcinomas. J Cancer Res Clin Oncol 120:502–504
   PubMed Web of Science ®Google Scholar
• Mohler JL, Williams BT, Thompson IM, Marshall ME. (1994). Coumarin (1,2-benzopyrone) for the treatment of prostatic carcinoma. J Cancer Res Clin Oncol 120:S35–38
   PubMed Web of Science ®Google Scholar
• Mollazadeh S, Matin MM, Bahrami AR, et al. (2011). Feselol enhances the cytotoxicity and DNA damage induced by cisplatin in 5637 cells. Z Naturforsch C 66:555–561
   PubMed Web of Science ®Google Scholar
• Mollazadeh S, Matin MM, Iranshahi M, et al. (2010). The enhancement of vincristine cytotoxicity by combination with feselol. J Asian Nat Prod Res 12:569–575
   PubMed Web of Science ®Google Scholar
• Moran E, O’Kennedy R, Thornes RD. (1987). Analysis of coumarin and its urinary metabolites by high-performance liquid chromatography. J Chromatogr 416:165–169
   PubMed Web of Science ®Google Scholar
• Myers RB, Parker M, Grizzle WE. (1994). The effects of coumarin and suramin on the growth of malignant renal and prostatic cell lines. J Cancer Res Clin Oncol 120:S11–S13
   PubMedGoogle Scholar
• Neshati V, Matin MM, Bahrami AR, et al. (2012). Increasing the cisplatin cytotoxicity and cisplatin-induced DNA damage by conferone in 5637 cells. Nat Prod Res 26:1724–1727
   PubMed Web of Science ®Google Scholar
• Neshati V, Matin MM, Iranshahi M, et al. (2009). Cytotoxicity of vincristine on the 5637 cell line is enhanced by combination with conferone. Z Naturforsch C 64:317–322
   PubMed Web of Science ®Google Scholar
• Omarbasha B, Fair WR, Heston WD. (1989). Effect of coumarin on the normal rat prostate and on the R-3327H prostatic adenocarcinoma. Cancer Res 49:3045–3049
   PubMed Web of Science ®Google Scholar
• Perel’son ME, Sheinker YN, Syrova GP, Turchin KF. (1970). NMR spectra of natural coumarin derivatives I. Coumarins. Chem Nat Comp 6:6–14
   Google Scholar
• Raev LD, Voinova E, Ivanov IC, Popov D. (1990). Antitumor activity of some coumarin derivatives. Die Pharmazie 45:696
   PubMed Web of Science ®Google Scholar
• Rassouli FB, Matin MM, Iranshahi M, et al. (2011). Investigating the enhancement of cisplatin cytotoxicity on 5637 cells by combination with mogoltacin. Toxicol In Vitro 25:469–474
   PubMed Web of Science ®Google Scholar
• Ratanasavanh D, Lamiable D, Biour M, et al. (1996). Metabolism and toxicity of coumarin on cultured human, rat, mouse and rabbit hepatocytes. Fundam Clin Pharmacol 10:504–510
   PubMed Web of Science ®Google Scholar
• Rautio A, Kraul H, Kojo A, Salmela E, Pelkonen O. (1992). Interindividual variability of coumarin 7-hydroxylation in healthy volunteers. Pharmacogenetics 2:227–233
   PubMedGoogle Scholar
• Ribble D, Goldstein NB, Norris DA, Shellman YG. (2005). A simple technique for quantifying apoptosis in 96-well plates. BMC Biotechnol 5:12
   PubMed Web of Science ®Google Scholar
• Riveiro ME, Moglioni A, Vàzquez R, et al. (2008). Structural insights into hydroxycoumarin-induced apoptosis in U-937 cells. Bioorg Med Chem 16:2665–2675
   PubMed Web of Science ®Google Scholar
• Rosenberg B, Vancamp L, Krigas T. (1965). Inhibition of cell division in Escherichia coli by electrolysis products from a platinum electrode. Nature 205:698–699
   PubMed Web of Science ®Google Scholar
• Rosenberg B, VanCamp L, Trosko JE, Mansour VH. (1969). Platinum compounds: a new class of potent antitumour agents. Nature 222:385–386
   PubMed Web of Science ®Google Scholar
• Stefanova TH, Nikolova NJ, Toshkova RA, Neychev HO. (2007). Anti-tumor and immunomodulatory effect of coumarin and 7-hydroxycoumarin against Sarcoma 180 in mice. J Exp Ther Oncol 6:107–115
   PubMedGoogle Scholar
• Thornes D, Daly L, Lynch G, et al. (1989). Prevention of early recurrence of high risk malignant melanoma by coumarin. Irish melanoma group. EJSO 15:431–435
   PubMed Web of Science ®Google Scholar
• Thornes RD, Daly L, Lynch G, et al. (1994). Treatment with coumarin to prevent or delay recurrence of malignant melanoma. J Cancer Res Clin Oncol 120:S32–S34
   PubMed Web of Science ®Google Scholar
• Vàzquez R, Riveiro ME, Vermeulen M, et al. (2012). Structure-anti-leukemic activity relationship study of ortho-dihydroxycoumarins in U-937 cells: key role of the δ-lactone ring in determining differentiation-inducing potency and selective pro-apoptotic action. Bioorg Med Chem 20:5537–5549
   PubMed Web of Science ®Google Scholar
• Von Angerer E, Kager M, Maucher A. (1994). Antitumour activity of coumarin in prostate and mammary cancer models. J Cancer Res Clin Oncol 120:S14–S16
   PubMed Web of Science ®Google Scholar
• Weber US, Steffen B, Siegers CP. (1998). Antitumor-activities of coumarin, 7-hydroxy-coumarin and its glucuronide in several human tumor cell lines. Research Commun Mol Pathol Pharmacol 99:193–206
   PubMed Web of Science ®Google Scholar